NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aqualung Therapeutics Corporation

Aqualung Therapeutics Corporation

Private
Tucson, ArizonaHealthcare & Life Scienceshttps://www.aqualungtherapeutics.com/

Last Round

Grant

Sep 15, 2025

Total Funding Raised

$14.93M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Aqualung Therapeutics Corporation is a biotechnology company that develops an immune-focused biologic platform for serious inflammatory disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

monoclonal antibodyimmunotherapeuticsacute respiratory distress syndromeARDSeNAMPT inhibitormAb therapyclinical-stage biotechcytokine stormfibrosis treatmentanti-inflammatory drugprogressive pulmonary fibrosisPPFbiomarker panelventilator-induced lung injuryVILI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aqualung Therapeutics Corporation Comparables

Compare Aqualung Therapeutics Corporation with similar companies based on industry and business-model similarity.

Aqualung Therapeutics Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Aqualung Therapeutics Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 15, 2025
Series A ExtensionJul 18, 2023
Series AOct 1, 2022
GrantSep 21, 2022
Convertible DebtJan 18, 2022
Grant
Jun 2, 2020

Aqualung Therapeutics Corporation Investors

Notable investors and investment history

Aqualung Therapeutics Corporation investors
InvestorRounds
NIH RADxGrant
Florida Venture ForumSeries A Extension
JSR Life SciencesConvertible Debt, Series A
DeepWork CapitalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 26, 2026

    Monthly visitors grew 108% MoM, reaching 1.9K.

  • Sep 15, 2025

    $1.2M grant received from NIH RADx.

Aqualung Therapeutics Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aqualung Therapeutics Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aqualung Therapeutics Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersTucson, Arizona
Employee Range5
Year Founded2016
Last FundingSep 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.